Researchers and clinicians typically administer 1-2mg/daily of GHK-Cu over the course of a 30-day treatment to achieve desirable outcomes on skin, hair growth, and systemic healing
Animal studies reveal doxorubicin administration causes dramatic weight loss and liver damage, evidenced by elevated plasma aspartate aminotransferase (AST) levels, an established marker of hepatotoxicity
The difference between BPC-157 and other peptides for recovery is shown in the table below
Please enable JavaScript to continue using this application.
Cell Discovery, 10(1), 74
Mechanism one (VGCC overactivation and eNOS uncoupling) : migraines, hemiplegic migraine, heart arrhythmias, long QT syndrome, neurological development disorders, mood and other mental health disorders, nervous system issues, neuropathic pain, IBS, and interstitial cystitis